“From 2019 to 2024, the percentage of adult patients with a diagnosis of overweight or obesity increased 50.7 percent, and ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern ...

A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...

Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss. Should ...

GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...

GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...